Paul Jeffrey, PharmD, examines different contracting strategies that can help improve patient access to prescription digital therapeutics (PDTs).
PCOC 2025 to Bring More Experts, More Engagement Than Ever
Explore cutting-edge discussions on patient-centered oncology, value-based care, AI innovations, and survivorship strategies Thursday and Friday at PCOC 2025 in Nashville.
Read More
High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management
This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.
Listen
CSU More Burdensome in Female Patients, Especially in Midlife
Female patients with chronic spontaneous urticaria (CSU) face greater disease severity and burdens, particularly in midlife, a study found.
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
Rocatinlimab AD Combo Therapy Safe, Effective Over 24 Weeks
Findings from the ROCKET-SHUTTLE trial reveal the benefits of combining the anti-OX40 monoclonal antibody with topical therapies for atopic dermatitis.
Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
Efgartigimod shows promising early response in generalized myasthenia gravis, especially in patients with short disease duration and severe bulbar symptoms.